普米克令舒联合博利康尼治疗喘憋性肺炎疗效观察

Observation on the curative effect of asthmatic suffocating pneumonia by Budesonide Suspension for Inhalation and Bricanyl

目的：探讨普米克令舒联合博利康尼治疗喘憋性肺炎治疗效果。方法：120例喘憋性肺炎患儿随机分为观察组和对照组。对照组54例给予常规肺炎治疗及普米克令舒雾化。观察组66侧在对照组治疗基础上联合博利康尼雾化吸入治疗。比较两组疗效及症状、体征消失时间及住院时问方面的差异。结果：临床研究显示，观察组疗效明显优于对照组，且症状体征消失时间和平均住院日明显缩短，进行统计学比较差异有显著性（P〈0．05）。结论：普米克令舒联合博利康尼治疗喘憋性肺炎安全有效，给药途径方便，可作为佐治喘憋性肺炎的主要药物，值得临床推广应用。

Objective： Exploring the curative effect of asthmatic suffocating pneumonia by Budesonide Suspension for Inhalation and Bricanyl. Method： One hundred and twenty infants with asthmatic suffocating pneumonia are divided into study group and control group in random. Fifty--four patients in control group are treated with routine pneumonia treatment and nebulized budesonide. Sixty-- six patients in study group are treated with nebulized bricanyl besides from con- trol group treatment. Then compare the differences of the curative effect, curative effect, vanishing time of symptoms and signs and the length of hospital stay of these two groups. Result： The clinical study shows that the curative effect of study group is apparently better than control group and vanishing time of symp- toms and signs and the length of hospital stay is apparently shorter than those of control group which has a significant difference by the compare of statistics. （ p〈0.05） Conclusion： The treatment of asthmatic suffocating pneumonia hy Budesonide Suspension for Inhalation and Bricanyl is safe and operative as well as convenient administration route which can be the main medicine of an add--on therapy to asthmatic suffocating pneumonia and worth clinical popularizing and application.